相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TRAIL-Armed ER Nanosomes Induce Drastically Enhanced Apoptosis in Resistant Tumor in Combination with the Antagonist of IAPs (AZD5582)
Huan Hou et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Extracellular Vesicle Delivery of TRAIL Eradicates Resistant Tumor Growth in Combination with CDK Inhibition by Dinaciclib
Changhong Ke et al.
CANCERS (2020)
TRAIL therapy and prospective developments for cancer treatment
Bindu Thapa et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Immunotherapy for Hepatocellular Carcinoma: A 2021 Update
Christo Kole et al.
CANCERS (2020)
A combined eat me/don't eat me strategy based on extracellular vesicles for anticancer nanomedicine
Zakia Belhadj et al.
JOURNAL OF EXTRACELLULAR VESICLES (2020)
The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects
Weiwei Tang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer
Carlotta Spano et al.
SCIENTIFIC REPORTS (2019)
The TRAIL to cancer therapy: Hindrances and potential solutions
Sonia How Ming Wong et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Extracellular vesicle-based drug delivery systems for cancer treatment
Sierra Walker et al.
THERANOSTICS (2019)
Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions
Katarzyna Ciacma et al.
MICROBIAL CELL FACTORIES (2018)
Every step of the way: integrins in cancer progression and metastasis
Hellyeh Hamidi et al.
NATURE REVIEWS CANCER (2018)
Exploring the TRAILs less travelled: TRAIL in cancer biology and therapy
Silvia von Karstedt et al.
NATURE REVIEWS CANCER (2017)
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy
Dae Won Kim et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
ZhengQiang Yuan et al.
JOURNAL OF EXTRACELLULAR VESICLES (2017)
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
James P. K. Armstrong et al.
ACS NANO (2017)
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
Zhengqiang Yuan et al.
CYTOTHERAPY (2016)
Tumor-Derived Exosomes Elicit Tumor Suppression in Murine Hepatocellular Carcinoma Models and Humans In Vitro
Quan Rao et al.
HEPATOLOGY (2016)
Inhibitory mechanisms of glabridin on tyrosinase
Jianmin Chen et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2016)
Mesenchymal stromal cell delivery of full-length tumor necrosis factor-related apoptosis-inducing ligand is superior to soluble type for cancer therapy
Zhengqiang Yuan et al.
CYTOTHERAPY (2015)
Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines
R. Polanski et al.
CELL DEATH & DISEASE (2015)
Prognosis of Untreated Hepatocellular Carcinoma
Edoardo G. Giannini et al.
HEPATOLOGY (2015)
Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
Feng Wang et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
Elizabeth K. Sage et al.
THORAX (2014)
Death receptors as targets in cancer
O. Micheau et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)
Edward J. Hennessy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
On the TRAIL to successful cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics
L. Y. Dimberg et al.
ONCOGENE (2013)
Phase I Trial of a Glypican-3-Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
Yu Sawada et al.
CLINICAL CANCER RESEARCH (2012)
Exosome-mediated delivery of siRNA in vitro and in vivo
Samir El-Andaloussi et al.
NATURE PROTOCOLS (2012)
Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy
Serena Rubina Baglio et al.
FRONTIERS IN PHYSIOLOGY (2012)
Death Receptor Agonists as a Targeted Therapy for Cancer
Jeffrey Wiezorek et al.
CLINICAL CANCER RESEARCH (2010)
Targeting IAPs as An Approach to Anti-Cancer Therapy
Christopher S. Straub
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection
A Kato et al.
JOURNAL OF SURGICAL ONCOLOGY (2001)
分享论文
